CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-04-03 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (right to buy) | −4,781 | 77,634 | ||
| 2017-03-29 | McCourt Marion Director | Grant or award · Stock Option (right to buy) | +28,000 | 28,000 | ||
| 2017-03-27 | Canaan IX L.P. Director | Other disposition | −750,000 | 2,494,381 | ||
| 2017-03-27 | THIRD ROCK VENTURES LP 10% owner | Sale | −650,000 | $18.00 | $11.7M | 5,170,348 |
| 2017-03-27 | Exter Neil Director | Sale | −0 | 0 | ||
| 2017-03-23 | THIRD ROCK VENTURES LP 10% owner | Sale | −1,000,000 | $17.00 | $17.0M | 5,820,348 |
| 2017-03-23 | Exter Neil Director | Sale | −0 | 0 | ||
| 2017-03-20 | Goeltz II Robert C. Chief Financial Officer | Option exercise | +21,517 | $4.47 | $96K | 31,306 |
| 2017-03-20 | Goeltz II Robert C. Chief Financial Officer | Sale | −10,000 | $19.60 | $196K | 21,306 |
| 2017-03-20 | Goeltz II Robert C. Chief Financial Officer | Sale | −11,517 | $20.00 | $230K | 9,789 |
| 2017-03-20 | Goeltz II Robert C. Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −21,517 | 217,658 | ||
| 2017-03-20 | McCarthy Sean A. President and CEO | Option exercise | +14,343 | $0.95 | $14K | 16,322 |
| 2017-03-20 | McCarthy Sean A. President and CEO | Sale | −14,343 | $19.60 | $281K | 1,979 |
| 2017-03-20 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −14,343 | 82,415 | ||
| 2017-03-15 | THIRD ROCK VENTURES LP 10% owner | Other disposition | −850,000 | 6,820,348 | ||
| 2017-03-09 | Goeltz II Robert C. Chief Financial Officer | Option exercise | +2,500 | $4.47 | $11K | 9,789 |
| 2017-03-09 | Goeltz II Robert C. Chief Financial Officer | Option exercise · Stock Option (right to buy) | −2,500 | 239,175 | ||
| 2017-03-03 | McCarthy Sean A. President and CEO | Option exercise | +14,343 | $1.13 | $16K | 16,322 |
| 2017-03-03 | McCarthy Sean A. President and CEO | Sale | −14,343 | $15.00 | $215K | 1,979 |
| 2017-03-03 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −14,343 | 366,961 |
Page 26 of 33 · 649 trades